# Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)

> **NCT07549295** · PHASE1 · ENROLLING_BY_INVITATION · sponsor: **Xinhua Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 240 (estimated)

## Conditions studied

- Fetal Growth Restriction (FGR)

## Interventions

- **DRUG:** Melatonin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07549295
- **Lead sponsor:** Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-01-01
- **Primary completion:** 2026-11-30
- **Final completion:** 2028-11-30
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2026-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07549295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07549295, "Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07549295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*